Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®".
Toumi
Mondher
M
Vesikari
Timo
T
Giaquinto
Carlo
C
D002648:Child; D003362:Cost-Benefit Analysis; D006801:Humans; D007114:Immunization / Q000191:economics*; D022243:Rotavirus Vaccines / Q000191:economics*; D014613:Vaccines, Attenuated / Q000191:economics
C492457:RIX4414 vaccine; C492535:RotaTeq; D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated